VICTORIA, BC, Oct. 24 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation , an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients living with less common diseases, announced today that the company will release financial results for the third quarter of 2005 after market close on Wednesday, November 2. The Company will hold a conference call and webcast beginning at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss results and to provide a general corporate update.
The webcast and conference call will be available to all interested parties. To access the live call or the archive via the Internet, please visit the Company’s website at www.aspreva.com in the Investors section. Alternatively, please dial 1 (877) 704-5381 (North America) or 1 (913) 312-1295 (International) to participate in the call. The call will be available for replay until November 9, 2005 by calling 1 (888) 203-1112 (North America) or 1 (719) 457-0820 (International) and entering the pass code 8817048.
About Aspreva Pharmaceuticals
Aspreva identifies, develops and upon regulatory approval, commercializes new indications for approved drugs and late stage drug candidates for patients living with less common diseases. Aspreva’s “Indication Partnering” strategy allows its partners to maintain core brand focus while extending the benefits of their medicines to a broader patient population.
For further information please contact: Sage Baker Director, Corporate Communications Aspreva Pharmaceuticals 250-744-2488 ext. 270 sbaker@aspreva.com
Aspreva Pharmaceuticals
CONTACT: Sage Baker, Director, Corporate Communications, AsprevaPharmaceuticals, (250) 744-2488 ext. 270, sbaker@aspreva.com
